Armstrong and colleagues discover that combined targeting of IKAROS and MENIN is a therapeutic strategy for acute myeloid leukemia through disruption of essential leukemogenic transcriptional programs.
- Brandon J. Aubrey
- Jevon A. Cutler
- Scott A. Armstrong